Will these two drugs save Pfizer????

In year 2012 I will consider November as the best month for Pfizer as it has got approval for two important drugs which the analyst and the scientists believe that will mark a difference for Pfizer in terms of the blockbuster game, though now a days in the pharma world more than the blockbuster image it’s the overall maintenance of the market value....... Pfizer got approval for its two major products where in the market is very lucrative.......Tofacitinib and Eliquis are a class drug in their own way but will both these drugs be able to reach Lipitor sales status as expected....only time will say?